School of Biomedical Sciences, University of Nottingham
Nottingham, Nottinghamshire, NG7 2UH, United Kingdom
NCT Number: NCT01050140
Dietary consumption of fructose has increased by nearly 50% since 1960.
A high fructose diet (HFrD) results in greater visceral adiposity and systemic insulin resistance than a high glucose diet. The effects of fructose on liver fatty acid and ATP stores, systemic oxidative stress and cardiovascular status are not fully known.
Looking for future studies?
Notify Me18 year–50 year
Male
Interventional
Not applicable
Nottingham, Nottinghamshire, NG7 2UH, United Kingdom
The protocol will assess the following outcomes:
Factors critical to carbohydrate metabolism such as systemic insulin resistance, body composition, energy expenditure, physical activity will also be assessed.
32 centrally overweight healthy males with a low baseline fructose intake will be recruited. They will be randomised double blindly to receive 25% of their dietary energy requirements from either fructose or glucose for 14 days.
The sugars will first be taken in an energy balanced and then an overfeeding setting.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
25% of dietary energy from fructose or glucose
Time frame: 2 weeks
Time frame: 2 weeks
Time frame: 2 weeks
Time frame: 2 weeks
Time frame: 2 weeks
Time frame: 2 weeks
Time frame: 2 weeks
Time frame: 2 weeks
Time frame: 2 weeks
University of Nottingham
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07564947
Digestive System Diseases, Fatty Liver
Peshawar, Khyber Pakhtunkhwa, Pakistan
View Trial DetailsNCT06297434
Digestive System Diseases, Fatty Liver
Busan, South Korea
View Trial DetailsNCT02520609
Digestive System Diseases, Fatty Liver
Bethesda, Maryland, United States
View Trial DetailsNCT07730905
Blood-Borne Infections, Chronic Disease
Foshan, Guangdong, China
View Trial Details